According to the National Institute for Health and Clinical Excellence, Avastin is not a cost-effective drug for the treatment of advanced bowel cancer.

It is estimated that every year the NHS would require a huge amount of £135 million to treat around 6,500 people at the cost of £20,800 per human being.

The Government has decided to use £50 million as Cancer Drugs Fund for the expenses that are required for this pricey treatment.

It is very difficult and painful for a doctor to tell his/her patients that they have very little time to live and it is even more difficult to say that the drug that can increase the survival rate can no longer be used because the medication is quite expensive.

It is worth mentioning that bowel cancer disease is the third most prevalent disease in the United Kingdom and around 35,000 cases are reported each year.

Although it is said that almost 16,000 people die every year because of bowel cancer, the survival rate has increased three times in the last 20 years in developed nations because of the Avastin drug.

Barbara Moss is a perfect example of Avastin drug survival, which prolonged her life by 21 months.